Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 100 patients with small-cell lung cancer: a mature follow-up report (Q78027906)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 May 1999

Language	Label	Description	Also known as
English	Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 100 patients with small-cell lung cancer: a mature follow-up report	scientific article published on 01 May 1999

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416006 AND SRC:MED&resulttype=core&format=json

10 December 2019

Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 100 patients with small-cell lung cancer: a mature follow-up report (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416006 AND SRC:MED&resulttype=core&format=json

10 December 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

S Fetscher

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416006 AND SRC:MED&resulttype=core&format=json

10 December 2019

W Brugger

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416006 AND SRC:MED&resulttype=core&format=json

10 December 2019

R Engelhardt

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416006 AND SRC:MED&resulttype=core&format=json

10 December 2019

L Kanz

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416006 AND SRC:MED&resulttype=core&format=json

10 December 2019

J Hasse

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416006 AND SRC:MED&resulttype=core&format=json

10 December 2019

H Frommhold

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416006 AND SRC:MED&resulttype=core&format=json

10 December 2019

W Lange

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416006 AND SRC:MED&resulttype=core&format=json

10 December 2019

R Mertelsmann

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416006 AND SRC:MED&resulttype=core&format=json

10 December 2019

publication date

1 May 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416006 AND SRC:MED&resulttype=core&format=json

10 December 2019

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416006 AND SRC:MED&resulttype=core&format=json

10 December 2019

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416006 AND SRC:MED&resulttype=core&format=json

10 December 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416006 AND SRC:MED&resulttype=core&format=json

10 December 2019

561-567

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416006 AND SRC:MED&resulttype=core&format=json

10 December 2019

Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working Party

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

Long term results of a phase I/II study of aggressive chemotherapy and sequential upper and lower hemibody radiation for patients with extensive stage small cell lung cancer

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

Limited-stage small-cell lung cancer: patient survival after combined chemotherapy and radiation therapy with and without treatment protocols

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

Thoracic and cranial radiotherapy for limited-stage small cell lung cancer

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

Limited-stage small cell lung cancer: local failure after chemotherapy and radiation therapy

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of thoracic radiotherapy in the management of limited-stage small cell lung cancer: past, present, and future

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylactic cranial irradiation in limited-stage small cell lung cancer

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison between resected and irradiated small cell lung cancer in patients in stages I through IIIa

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective randomized trial to determine the benefit of surgical resection of residual disease following response of small cell lung cancer to combination chemotherapy

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

The results of treatment in 100 patients with limited-stage small cell lung cancer

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

Multimodal therapy of small cell lung cancer in TNM stages I through IIIa

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18 years--an analysis of 1,714 consecutive patients

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

Carboplatin, etoposide, and accelerated hyperfractionated radiotherapy for elderly patients with limited small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive therapy for small-cell lung cancer using carboplatin alternating with cisplatin, ifosfamide, etoposide, mid-cycle vincristine, and radiotherapy

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

Carboplatin, etoposide, and ifosfamide as intensive chemotherapy for small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group pilot study

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

Can cytotoxic dose-intensity be increased by using granulocyte colony-stimulating factor? A randomized controlled trial of lenograstim in small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

Routine use of granulocyte colony-stimulating factor is not cost-effective and does not increase patient comfort in the treatment of small-cell lung cancer: an analysis using a Markov model

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced myelotoxicity due to granulocyte colony-stimulating factor administration until 48 hours before the next chemotherapy course in patients with small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-Intensive Therapy in Small Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-intensity meta-analysis of chemotherapy regimens in small-cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose combined alkylating agent therapy with autologous stem cell support and chest radiotherapy for limited small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-intensive therapy in lung cancer

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicyclic, dose-intensive chemotherapy supported by sequential reinfusion of hematopoietic progenitors in whole blood

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose carmustine and autologous bone marrow reinfusion in the treatment of refractory or relapsed small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

Late intensification in small-cell lung cancer: a phase I study of high doses of cyclophosphamide and etoposide with autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose cyclophosphamide with autologous bone marrow rescue after conventional chemotherapy in the treatment of small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive chemotherapy with autologous bone marrow transplantation for small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose intensification therapy with autologous bone marrow support for limited small-cell bronchogenic carcinoma

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy with autologous bone marrow/stem-cell rescue in lung cancer

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-small-cell lung cancer. Major cause of late mortality in patients with small cell lung cancer

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

New Agents in the Treatment of Small Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of all-trans-retinoic acid plus cisplatin and etoposide in patients with extensive stage small cell lung carcinoma: an Eastern Cooperative Oncology Group Study.

1 reference

https://api.crossref.org/works/10.1023/A:1026453922931

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1026453922931

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416006 AND SRC:MED&resulttype=core&format=json

10 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10416006 AND SRC:MED&resulttype=core&format=json

10 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q78027906&oldid=1582968084"